Carelon Health Services To Cover Guardant Health’s Shield Blood Test
Largest national medical benefit manager in the U.S. expands coverage for FDA-approved Shield blood test for colorectal cancer (CRC) screening to eligible policyholdersIncreasing total covered Shield lives ages 45 and
A big health insurance company decided to pay for Guardant's blood test that finds colon cancer early. This is good news because more people can now use the test, which helps the company grow its business.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.